Nobel prize medal.svg

Greg Winter

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Sir Greg Winter

Greg Winter EM1B5921 (31295405977).jpg
Gregory Winter in December 2018
Born (1951-04-14) 14 April 1951 (age 68)[1]
ResidenceCambridge, Cambridgeshire, U.K.
EducationRoyal Grammar School, Newcastle upon Tyne
Alma materUniversity of Cambridge (MA, PhD)
Known for
Awards
Scientific career
FieldsBiochemistry
Institutions
ThesisThe amino acid sequence of tryptophanyl tRNA synthetase from Bacillus stearothermophilus (1977)
Doctoral advisor
Websitetrin.cam.ac.uk/about/master-fellows/master/winter/

Sir Gregory Paul Winter CBE FRS FMedSci (born 14 April 1951) is a British biochemist. He is best known for his work on the therapeutic use of monoclonal antibodies. He invented techniques to both humanise (1986) and, later, to fully humanise using phage display, antibodies for therapeutic uses.[5]

Winter won the 2018 Nobel Prize in Chemistry along with George P. Smith and Frances Arnold.[6]

References[change | change source]

  1. WINTER, Sir Gregory (Paul). ukwhoswho.com. Who's Who. 2016 (online Oxford University Press ed.). A & C Black, an imprint of Bloomsbury Publishing plc. closed access (subscription required)
  2. "EMBO MEMBER: Gregory P. Winter". people.embo.org.
  3. "Announcement of the Prince Mahidol Award 2016". princemahidolaward.org. Retrieved 13 June 2017.
  4. "Nobel Prize in Chemistry 2018 - live". Retrieved 3 October 2018.
  5. McCafferty, J.; Griffiths, A.; Winter, G.; Chiswell, D. (1990). "Phage antibodies: filamentous phage displaying antibody variable domains". Nature 348 (6301): 552–554. doi:10.1038/348552a0. PMID 2247164. 
  6. "Live blog: direction evolution takes chemistry Nobel prize". Retrieved 3 October 2018.